|
|
Volumn 339, Issue 7, 1998, Pages 472-474
|
|
Vascular targeting as a strategy for cancer therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARGINYLGLYCYLASPARTIC ACID;
ASPARAGINYLGLYCYLARGININE;
DOXORUBICIN;
INTEGRIN;
TRIPEPTIDE;
UNCLASSIFIED DRUG;
ANGIOGENESIS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CANCER THERAPY;
DRUG CONJUGATION;
DRUG TARGETING;
ENDOTHELIUM CELL;
HUMAN;
MOUSE;
NONHUMAN;
PHAGE DISPLAY;
PRIORITY JOURNAL;
TUMOR VASCULARIZATION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
DOXORUBICIN;
DRUG CARRIERS;
ENDOTHELIUM, VASCULAR;
HUMANS;
MICE;
NEOPLASMS;
PEPTIDES;
|
|
EID: 0032514402
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199808133390711 Document Type: Article |
|
Times cited : (86)
|
|
References (7)
|
